Chronic Lymphocytic Leukemia News and Research

RSS
Chronic Lymphocytic Leukemia (CLL) is the most common form of leukemia in adults. According to the American Cancer Society, approximately 8,000 patients will be diagnosed this year. More than 60,000 people in the U.S. currently have CLL. The disease arises in lymphocytes, a type of white blood cell that normally produces antibodies and serves important immune functions.
COVID-19 patient with repeatedly undetectable SARS-CoV-2 antibodies

COVID-19 patient with repeatedly undetectable SARS-CoV-2 antibodies

Clinical study evaluates potential of oral cancer drug to reduce respiratory symptoms of COVID-19

Clinical study evaluates potential of oral cancer drug to reduce respiratory symptoms of COVID-19

Dual inhibitor therapy may be safer for CLL patients, Moffitt study shows

Dual inhibitor therapy may be safer for CLL patients, Moffitt study shows

New NCCN guidelines explain how to recognize and manage immunotherapy-related side effects

New NCCN guidelines explain how to recognize and manage immunotherapy-related side effects

New drug can prevent life-threatening anaphylaxis, shows study

New drug can prevent life-threatening anaphylaxis, shows study

Dana-Farber launches clinical test of blood cancer drug in COVID-19 patients

Dana-Farber launches clinical test of blood cancer drug in COVID-19 patients

Drug combo for untreated CLL approved by FDA based on E1912 trial

Drug combo for untreated CLL approved by FDA based on E1912 trial

Greater occurrence of infections correlates with future cancer diagnosis

Greater occurrence of infections correlates with future cancer diagnosis

New prognostic tool could help improve clinical decision making for leukemia patients

New prognostic tool could help improve clinical decision making for leukemia patients

New prognostic tool helps leukemia patients plan for cancer treatment

New prognostic tool helps leukemia patients plan for cancer treatment

Single gene cluster loss promotes initiation and progression of multiple myeloma in mice

Single gene cluster loss promotes initiation and progression of multiple myeloma in mice

Universal 'One-Size-Fits-All' Cancer Treatment

Universal 'One-Size-Fits-All' Cancer Treatment

CD19 CAR NK cell therapy clinical trial shows encouraging results for hematologic cancers

CD19 CAR NK cell therapy clinical trial shows encouraging results for hematologic cancers

AMSBIO announces new Custom CAR-T development service

AMSBIO announces new Custom CAR-T development service

FDA gives clearance to IND application for Calibr's 'switchable' CAR-T cell therapy

FDA gives clearance to IND application for Calibr's 'switchable' CAR-T cell therapy

Researchers reveal mutation's role in blood cancers

Researchers reveal mutation's role in blood cancers

Study may help develop ibrutinib-based combination therapies for blood cancer

Study may help develop ibrutinib-based combination therapies for blood cancer

OGT launches high-quality NGS panel for research into Chronic Lymphocytic Leukemia

OGT launches high-quality NGS panel for research into Chronic Lymphocytic Leukemia

Risk of specific genetic translocation is higher in patients of African ancestry, shows study

Risk of specific genetic translocation is higher in patients of African ancestry, shows study

New strategies needed to manage ibrutinib-related toxicities in CLL patients, study suggests

New strategies needed to manage ibrutinib-related toxicities in CLL patients, study suggests